CZ20011819A3 - Use of phosphonoformic acid derivatives for treating infections - Google Patents

Use of phosphonoformic acid derivatives for treating infections

Info

Publication number
CZ20011819A3
CZ20011819A3 CZ20011819A CZ20011819A CZ20011819A3 CZ 20011819 A3 CZ20011819 A3 CZ 20011819A3 CZ 20011819 A CZ20011819 A CZ 20011819A CZ 20011819 A CZ20011819 A CZ 20011819A CZ 20011819 A3 CZ20011819 A3 CZ 20011819A3
Authority
CZ
Czechia
Prior art keywords
acid derivatives
treating infections
phosphonoformic acid
phosphonoformic
infections
Prior art date
Application number
CZ20011819A
Other languages
Czech (cs)
Inventor
Hassan Jomaa
Original Assignee
Jomaa Pharmaka Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jomaa Pharmaka Gmbh filed Critical Jomaa Pharmaka Gmbh
Publication of CZ20011819A3 publication Critical patent/CZ20011819A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04Amoebicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
CZ20011819A 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections CZ20011819A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19854310A DE19854310A1 (en) 1998-11-25 1998-11-25 Use of phosphonoformic acid derivatives for the therapeutic and prophylactic treatment of infections

Publications (1)

Publication Number Publication Date
CZ20011819A3 true CZ20011819A3 (en) 2001-12-12

Family

ID=7888924

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20011819A CZ20011819A3 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections

Country Status (16)

Country Link
EP (1) EP1133302A2 (en)
JP (1) JP2002530343A (en)
CN (1) CN1328464A (en)
AP (1) AP2001002164A0 (en)
AU (1) AU1859100A (en)
BR (1) BR9915605A (en)
CA (1) CA2352511A1 (en)
CZ (1) CZ20011819A3 (en)
DE (1) DE19854310A1 (en)
EA (1) EA200100585A1 (en)
IL (1) IL142775A0 (en)
NO (1) NO20012540L (en)
OA (1) OA11718A (en)
PL (1) PL348354A1 (en)
TR (1) TR200101431T2 (en)
WO (1) WO2000030653A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1408984E (en) 2001-07-20 2008-12-26 Bioagency Ag Organo-phosphorous compounds for activating gamma/delta t cells
CA2518763A1 (en) * 2003-03-14 2004-09-23 Epistem Limited Treatment and/or prevention of non-viral epithelial damage
US20050171063A1 (en) * 2003-10-20 2005-08-04 Pawan Malhotra Use of phosphono derivatives as anti-malarials
CN104940211B (en) * 2015-06-08 2018-06-19 广州万粤知识产权运营有限公司 Application of the betulic acid in antimycotic biofilm drug is prepared

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995012604A1 (en) * 1993-11-05 1995-05-11 Aktiebolaget Astra Novel amino acid derivatives
SE9604582D0 (en) * 1996-12-13 1996-12-13 Astra Ab Novel compounds
RU2116790C1 (en) * 1997-07-02 1998-08-10 Закрытое акционерное общество "Рефарм" Antiinfectious agent "repharm" for external using
DE19859668A1 (en) * 1998-06-24 1999-12-30 Hassan Jomaa Treating or preventing viral, bacterial, fungal or parasitic infections using bis-phosphonic acid compounds, also having herbicidal activity

Also Published As

Publication number Publication date
EA200100585A1 (en) 2002-04-25
IL142775A0 (en) 2002-03-10
AP2001002164A0 (en) 2001-06-30
JP2002530343A (en) 2002-09-17
WO2000030653A2 (en) 2000-06-02
EP1133302A2 (en) 2001-09-19
AU1859100A (en) 2000-06-13
OA11718A (en) 2005-01-26
NO20012540D0 (en) 2001-05-23
CA2352511A1 (en) 2000-06-02
BR9915605A (en) 2001-08-14
PL348354A1 (en) 2002-05-20
WO2000030653A3 (en) 2000-11-16
NO20012540L (en) 2001-07-24
CN1328464A (en) 2001-12-26
TR200101431T2 (en) 2001-10-22
DE19854310A1 (en) 2000-06-29

Similar Documents

Publication Publication Date Title
HUP0100765A3 (en) Composition for the treatment of halitosis
AU2301699A (en) System for the treatment of wafers
HUP0201393A3 (en) Use of xenon for treating neurointoxications
HUP0105154A3 (en) Use of anticonvulsant derivatives for treating cluster headaches
HK1038691A1 (en) Antibiotic compositions for treatment of the eye
PL342076A1 (en) Method of treating surfaces
MXPA00012647A (en) N-substituted derivatives of 5-oxyiminobarbituric acid.
IL142776A0 (en) Use of phosphonoformic acid derivatives for treating infections
IL133760A0 (en) Composition for the treatment of dandruff
IL142775A0 (en) Use of phosphonoformic acid derivatives for treating infections
PL344523A1 (en) Method for treatment of aqueous streams comprising biosolids
GB2344586B (en) Isoquinuclidine derivatives,method of manufacturing the same and therapeutic agents for hypercholesterolemia containing these compounds
AU1940800A (en) Combination therapy for the treatment of sepsis
EP1096927A4 (en) Composition for treatment of stress
IL124764A0 (en) Topical composition for treatment of baldness
NO20006383L (en) Process of treatment
PL355625A1 (en) Use of formulations for treating surfaces for temporarily improving dirt-removing behavior
AU1036801A (en) Agent for treating cephalic pain
GB9922462D0 (en) The use of triazolo-pyridazine derivatives for treating hearing loss
IL124878A0 (en) Composition for the treatment of seborrhea
GB9713255D0 (en) Process for treatment of surfaces
SI1068184T1 (en) N-aryloxyethylamine derivatives for the treatment of depression
AU2429200A (en) Agent for inhibiting the regeneration of tissue
AU2270100A (en) Method for the treatment of bone loss
IL121227A0 (en) Composition for the treatment of seborrhea